Ebpay生命

info@dovepress.co.uk +44-1625 509 130

Biomedicine Research Journals
生物医药期刊精选

迅速、专业、友好的出版体验

稿件提交、同行评审、编辑流程、论文出版全流程服务和支持
分析更多
Biologics: Targets and Therapy

Biologics: Targets and Therapy
《生物制剂:靶点和治疗》

期刊指标

2023影响因子:
5.3 (Q1)
CiteScore:
8.3 (Q1)

ISSN:
1177-5491
年度下载/阅读量:
56,812
投稿至收到专家评审结果平均时间:
37 天
从接受发表到正式出版平均时间:
8 天
稿件接受率:
33%
提交新稿件 查看我的稿件状态

关于期刊

Biologics: Targets and Therapy (《生物制剂:靶点和治疗》)专注于生物制剂及其生物仿制药研究,致力于探索癌症、自身免疫性疾病或其他可识别分子靶点的病理生理学原理和临床应用。

Biologics: Targets and Therapy 的特点是快速报道原创研究、综述、基础科学、临床研究和评论等类型的文章,研究焦点包括:

  • 基因治疗:挖掘基因编辑技术的潜力,为遗传性疾病给予新的治疗策略。
  • 细胞疗法:利用细胞的再生能力,修复和替换受损组织。
  • 抗体治疗:开发精准靶向的抗体药物,提高治疗效果,减少副作用。
  • 疫苗研发:创新疫苗设计,预防和控制传染病。
  • 激素与细胞因子:研究激素和细胞因子在调节生理过程中的作用。

本刊不接收研究方案或荟萃分析;只接收对文献做出有价值和原创性贡献的病例报告。

本刊是Committee on Publication Ethics (COPE) 的成员之一,遵循COPE的原则。期刊还被收录于ESCI、 PubMed、Scopus、DOAJ、Embase、OAIster等线上索引中。

已发表论文

Authors: Shengyang Liu, Hui Zhao, Li Shi, Hongzhi Ji

Received: 12 June 2024

Accepted for publication: 19 October 2024

Published: 24 October 2024 Volume 2024:18 Pages 307—311

DOI: http://doi.org/10.2147/BTT.S482138

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Professor Shein-Chung Chow

摘要: 鼻眶血管瘤是一种常见的成人良性眶内病变,复发性病例在传统手术治疗后仍面临较高的复发风险及并发症。本报告介绍了一例21岁男性患者,先后接受多次手术治疗后血管瘤复发,且伴随严重鼻出血,手术已无法进一步控制病情。采用抗血管生成药物贝伐单抗进行非手术治疗,显著缩小了肿瘤,并有效控制了症状。经过两年的随访观察,患者肿瘤未出现复发,且无严重不良反应。本案例表明,贝伐单抗可作为复发性鼻眶血管瘤的一种安全且有效的非手术治疗选择,为该类难治性血管瘤的治疗给予了新的方向。

Download Article

Authors: Wei Q, Lin N, Wang L

Received: 2 November 2024

Accepted for publication: 5 March 2025

Published: 18 March 2025 Volume 2025:19 Pages 113—123

DOI: http://doi.org/10.2147/BTT.S499314

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Dr Shein-Chung Chow

摘要

背景: 本研究旨在揭示DNA拓扑异构酶IIα(TOP2A)在视网膜母细胞瘤(RB)中的关键作用,重点关注其对上皮-间质转化(EMT)的调控机制,并探讨TOP2A抑制作为潜在治疗策略的临床应用价值。

方法: 顺利获得分析公共基因表达数据库(GSE97508、GSE110811和GSE172170)中的RB组织数据,我们评估了TOP2A的表达水平。随后,在人RB细胞系(Y79和WERI-Rb-1)中,顺利获得敲低或过表达TOP2A进行功能实验,检测其对细胞增殖、迁移、侵袭能力的影响,并利用RT-PCR和Western blot技术分析EMT标志物的表达变化。此外,我们在皮下移植瘤和肝转移小鼠模型中进一步验证了TOP2A调控对肿瘤生长和转移的抑制作用。

结果: RB组织中TOP2A的表达显著上调(p < 0.0001)。体外实验表明,敲低TOP2A可显著抑制RB细胞的增殖、迁移和侵袭能力,并逆转EMT标志物的表达(p < 0.05);而TOP2A过表达则促进了这些致癌过程。在体内实验中,敲低或抑制TOP2A显著减缓了皮下移植瘤和肝转移模型的肿瘤生长及转移(p < 0.05)。值得注意的是,TOP2A抑制剂与EMT抑制剂的联合治疗表现出协同抗肿瘤效应,显著降低了肿瘤负荷和转移病灶的数量(p < 0.01)。

结论: TOP2A在RB的发病机制和进展中扮演了核心角色,其顺利获得调控EMT促进了肿瘤的恶性表型。抑制TOP2A不仅能够有效抑制RB细胞的增殖和转移,还可逆转EMT过程,从而为RB的治疗给予了新的靶点。本研究为开发靶向TOP2A的治疗策略奠定了重要理论基础,并为后续临床转化研究给予了科学依据。

Download Article

Authors: Liu Z, Zhang F, Jia F, Li S, Jiang C, Ruan B, Long R

Received: 5 September 2024

Accepted for publication: 10 December 2024

Published: 27 December 2024 Volume 2024:18 Pages 453—468

DOI: http://doi.org/10.2147/BTT.S484410

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Dr Shein-Chung Chow

Purpose: Chronic suppurative otitis media (CSOM) is a prominent contributor to preventable hearing loss globally. Probiotic therapy has attracted research interest in human infectious and inflammatory disease. As the most prevalent probiotic, the role of Lactobacillus in CSOM remains poorly defined. This study aimed to investigate the antipathogenic effects and underlying mechanism of Lactobacillus on CSOM.

Methods: RNA sequencing of granulation of middle ear cavity from CSOM patients and lavage fluid of middle ear from normal volunteer was conducted. Human middle ear epithelial cells (HMEEC) and rats infected with Bacillus cereus (B. cereus) and Staphylococcus aureus (S. aureus) were used for CSOM constructing. Western blot, qPCR and Vybrant™ Alexa Fluor™ 488 lipid raft labeling were performed to explore the possible molecular mechanism by which lipid raft linker (RFTN1) regulates lipid raft/toll-like receptor 4 (TLR4). ELISA and HE staining was utilized to evaluate the effect of Lactobacillus on the progression of CSOM in vivo.

Results: Based on RNA Sequence analysis, a total of 3646 differentially expressed genes (1620 up-regulated and 2026 down-regulated) were identified in CSOM. RFTN1 was highly expressed in CSOM. Inhibition of RFTN1 not only reduced the inflammatory response of CSOM but also suppressed the formation of lipid rafts. Further investigation revealed that RFTN1 inhibition could reduce the expression of TLR4, which also localizes to the lipid rafts. TLR4 responds to RFTN1-mediated inflammatory responses in CSOM. We treated the CSOM model with Lactobacillus, which has great potential for alleviating the inflammatory response, and found that Lactobacillus attenuated the development of CSOM by reducing RFTN1 and TLR4 expression.

Conclusion: In conclusion, these findings suggest a crucial role for Lactobacillus in alleviating CSOM progression and uncovered the molecular mechanism involving Lactobacillus-regulated inhibition of the RFTN1-lipid raft-TLR4 signaling pathway under CSOM conditions.

Keywords: CSOM, Lactobacillus, RFTN1, TLR4, S. aureus, B. cereus

Download Article

查看本刊最新文章
Nanotechnology, Science and Applications

Nanotechnology, Science and Applications
《纳米技术:科学与应用》

期刊指标

2023影响因子:
4.9 (Q2)
CiteScore:
11.7 (Q1)

ISSN:
1177-8903
年度下载/阅读量:
36,361
投稿至收到专家评审结果平均时间:
41 天
从接受发表到正式出版平均时间:
27 天
稿件接受率:
40%
提交新稿件 查看我的稿件状态

关于期刊

Nanotechnology, Science and Applications (《纳米技术:科学与应用》)致力于纳米技术科学在广泛的工业和学术应用中的研究与开展,涵盖了生物医学、药物传递等方向。期刊聚焦于纳米技术在各个领域的应用,包括工程学、光学、生物医学、化妆品、纺织品、资源可持续性等。

该期刊以快速报道综述文章、原创研究和应用研究为特点,重点涉及纳米材料、纳米颗粒、纳米结构及其制备、诊断与分析、药物输送以及毒理学等领域的应用研究。期刊鼓励与纳米技术相关的跨学科研究,有助于其在现实世界中的应用和开展。《纳米技术:科学与应用》不再接受荟萃分析类文章的投稿。

中国科研实验室分区
根据2025年发布的中国科研实验室期刊分区表(升级版)显示:
  •  大类及分区:材料科学4区
  •  小类及分区:纳米科技4区

本刊是Committee on Publication Ethics (COPE) 的成员之一,遵循COPE的原则。期刊还被收录于ESCI、PubMed、Scopus、DOAJ、Embase、OAIster等线上索引中。

已发表论文

Authors: Gelaye Y , Luo H

Received: 30 January 2025

Accepted for publication: 10 April 2025

Published: 7 May 2025 Volume 2025:18 Pages 211—223

DOI: http://doi.org/10.2147/NSA.S520121

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Professor Kattesh Katti

Abstract: Aflatoxin contamination poses a significant challenge to global food safety, public health, and agricultural sustainability. Traditional methods for mitigating aflatoxins, such as chemical and physical detoxification techniques, often raise concerns about environmental harm, nutrient loss, and potential toxicity. In contrast, green-synthesized nanomaterials have emerged as an environmentally friendly and effective solution for controlling aflatoxins. This study explores the potential of green-synthesized nanomaterials for aflatoxin mitigation, focusing on their mechanisms of action, effectiveness, and long-term applicability in agricultural and food safety contexts. A comprehensive review of 116 articles on the latest developments in green nanotechnology was used, focusing on the creation, characterization, and application of nanoparticles, including silver, zinc oxide, titanium dioxide, and iron-based nanomaterials. Green nanoparticles reduce aflatoxin load primarily through their antioxidant properties, which neutralize oxidative stress, and their high adsorption capacity, which binds aflatoxins and reduces their bioavailability. Photocatalytic degradation, adsorption, and enzymatic detoxification were also evaluated. The results indicate that green-synthesized nanoparticles exhibit high efficacy, biocompatibility, and minimal environmental impact, especially when compared to traditional detoxification methods. However, challenges such as nanoparticle stability, large-scale production, regulatory issues, and potential long-term toxicity still require further investigation. To advance this field, future studies should focus on refining green synthesis processes, enhancing nanoparticle stability, and exploring the integration of nanotechnology with biosensors and smart packaging for real-time aflatoxin monitoring. By advancing these sustainable technologies, this research aims to contribute to the development of effective and safe methods for aflatoxin mitigation, thereby supporting global food security, public health, and environmental sustainability.

Download Article

Authors: Pajor-Świerzy A, Szczepanowicz K

Received: 20 December 2024

Accepted for publication: 25 March 2025

Published: 14 April 2025 Volume 2025:18 Pages 197—210

DOI: http://doi.org/10.2147/NSA.S509925

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Professor Kattesh Katti

Abstract: This mini-review paper gives a brief summary of recent works in the development of bimetallic core@shell nanoparticles composed of nickel (as a core) and a silver shell (Ni@Ag NPs). We present the methods of Ni@Ag NPs synthesis, ink preparation, and their coatings formation. We also place emphasis on the selection and optimization of the sintering process of materials based on Ni@Ag NPs. Finally, the challenges in the application of Ni@Ag NPs in printed conductive structures are presented.

Keywords: nickel@silver core@shell nanoparticles, conductive inks, sintering methods, conductive coatings, printed electronics

Graphical Abstract:

Download Article

Authors: Thungmungmee S, Sritularak B, Wisidsri N, Kanana N, Nimmano N

Received: 13 December 2024

Accepted for publication: 13 March 2025

Published: 24 March 2025 Volume 2025:18 Pages 157—171

DOI: http://doi.org/10.2147/NSA.S508582

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Professor Kattesh Katti

Purpose: The study aimed to investigate in vitro anti-aging activities of 29 Dendrobium spp. and develop and characterize microemulsions (MEs) for topical application.

Methods: Antioxidant activity was determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH), H2O2 scavenging, and ferric reducing antioxidant power (FRAP) assays. The anti-collagenase (MMP-1 and MMP-2) and anti-elastase activities were also evaluated. Cytotoxicity and human intracellular reactive oxygen species (ROS) levels were determined using resazurin reduction and 2′,7′-dichlorofluorescin diacetate (DCFDA) assays, respectively. D. kentrophyllum extract-loaded microemulsion (DKME) was then prepared and optimized. The stability of DKME was studied using a heating-cooling cycle.

Results: D. kentrophyllum appeared to be the best candidate anti-aging agent because of its antioxidant, anti-collagenase, and anti-elastase activities. The extract was safe for human skin cells at a concentration of 6.25– 100 μg/mL. It also decreased the intracellular ROS-induced ultraviolet B (UVB) irradiation compared to that in the control. DKME comprising Tween 80:ethanol (5:1), water, and isononyl isononanoate showed a suitable appearance, droplet size, polydisperse index, zeta potential, pH, and viscosity. This formulation demonstrated desirable physical and chemical stability, with non-cytotoxic effects.

Conclusion: DKME is considered a promising anti-aging product. However, an in vivo study of this optimized formulation might be evaluated in further study for anti-aging purposes.

Keywords: reactive oxygen species, anti-aging activities, Dendrobium kentrophyllum, microemulsion

Download Article

查看本刊最新文章
The Application of Clinical Genetics

The Application of Clinical Genetics
《临床遗传学应用》

期刊指标

2023影响因子:
2.6 (Q2)
CiteScore:
5.4 (Q2)

ISSN:
1178-704X
年度下载/阅读量:
54,226
投稿至收到专家评审结果平均时间:
49 天
从接受发表到正式出版平均时间:
16 天
稿件接受率:
31%
提交新稿件 查看我的稿件状态

关于期刊

The Application of Clinical Genetics (《临床遗传学应用》)欢迎发布在人类遗传学领域的实验室与临床研究成果,涵盖了基因疾病、遗传学机制、药物基因组学等。期刊专注于遗传学的各个方面,包括遗传学的基础研究和临床应用研究,尤其关注遗传性疾病的管理、机制探讨以及遗传咨询等领域。

本刊主要关注:

  • 群体遗传学
  • 功能遗传学
  • 遗传疾病的自然史
  • 遗传疾病的管理
  • 遗传疾病的机制
  • 遗传咨询与伦理问题
  • 动物模型
  • 药物基因组学
  • 产前诊断
  • 发育性畸形学

本刊是Committee on Publication Ethics (COPE) 的成员之一,遵循COPE的原则。期刊还被收录于ESCI、PubMed、Scopus、DOAJ、Embase、OAIster等线上索引中。

已发表论文

Authors: Andersen K , Hansen T , Jørgensen ME, Senftleber N

Received: 6 October 2023

Accepted for publication: 19 January 2024

Published: 2 February 2024 Volume 2024:17 Pages 15—21

DOI: http://doi.org/10.2147/TACG.S437484

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Prof. Dr. Martin Maurer

Background: Conradi–Hünermann–Happle syndrome (CDPX2, OMIM 302960) is an X-linked dominant inherited disorder caused by variants in the EBP gene, which primarily affects the skin, bones, and eyes.

Objective: To describe the clinical manifestations and genetic mutation in a 7-year-old girl presenting with severe scoliosis, hydronephrosis, and other skeletal abnormalities.

Methods: The patient's medical history was collected from birth. Exome sequencing was performed to identify candidate genes, and the detected variant was confirmed by Sanger sequencing.

Results: Exome sequencing revealed a de novo EBP mutation (c.452A>G, p.Gln151Arg) in the patient.

Conclusion: The patient was diagnosed with X-linked chondrodysplasia punctata type 2 (CDPX2). This novel missense mutation expands the mutation spectrum of CDPX2 and underscores the clinical utility of exome sequencing in diagnosing this condition.

Keywords: EBP, c.452A>G, p.Gln151Arg, exome sequencing, CDPX2

Download Article

Authors: Liu Y, Lan X, Lu J, Zhang Q, Zhou T, Ni T, Yan J

Received: 19 October 2023

Accepted for publication: 19 January 2024

Published: 1 February 2024 Volume 2024:17 Pages 1—13

DOI: http://doi.org/10.2147/TACG.S441784

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Prof. Dr. Martin Maurer

Objective: We evaluate whether next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy (PGT-A) improves the cumulative pregnancy outcomes of patients with unexplained recurrent implantation failure (uRIF) as compared to conventional in vitro fertilization or intracytoplasmic sperm injection (IVF/ICSI).

Patients and Methods: This was a retrospective cohort study (2015– 2022). A total of 705 couples diagnosed with uRIF were included in the study. 229 women transferred blastocysts based on morphological grading (IVF/ICSI) and 476 couples opted for PGT-A to screen blastocysts by NGS. Women were further stratified according to age at retrieval (< 38 years and ≥ 38 years). The primary outcome was the cumulative live-birth rate after all the embryos were transferred in a single oocyte retrieval or until achieving a live birth. Confounders were adjusted using binary logistic regression models.

Results: Cumulative live-birth rate was similar between the IVF/ICSI group and the PGT-A group after stratified by age: IVF/ICSI vs PGT-A in the < 38 years subgroup (49.7% vs 57.7%, adjusted OR (95% CI) = 1.25 (0.84– 1.84), P = 0.270) and in the ≥ 38 years subgroup (14.0% vs 19.5%, adjusted OR (95% CI) = 1.09 (0.41– 2.92), P = 0.866), respectively. Nonetheless, the PGT group had a lower first-time biochemical pregnancy loss rate (17.0% vs 8.7%, P = 0.034) and a higher cumulative good birth outcome rate (35.2% vs 46.4%, P = 0.014) than the IVF/ICSI group in the < 38 years subgroup. Other pregnancy outcomes after the initial embryo transfer and multiple transfers following a single oocyte retrieval were all similar between groups.

Conclusion: Our results showed no evidence of favorable effects of PGT-A treatment on improving the cumulative live birth rate in uRIF couples regardless of maternal age. Use of PGT-A in the < 38 years uRIF patients would help to decrease the first-time biochemical pregnancy loss and increase the cumulative good birth outcome.

Keywords: preimplantation genetic testing for aneuploidy, unexplained recurrent implantation failure, cumulative live-birth rate, cumulative good birth outcome

Download Article

Authors: Andersen K , Hansen T , Jørgensen ME, Senftleber N

Received: 6 October 2023

Accepted for publication: 19 January 2024

Published: 2 February 2024 Volume 2024:17 Pages 15—21

DOI: http://doi.org/10.2147/TACG.S437484

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Prof. Dr. Martin Maurer

Background: Congenital sucrase isomaltase deficiency (CSID) is in general a very rare disease. However, 2– 3% of the Greenlandic population are homozygous (HO) carriers of an Arctic-specific loss-of-function (LoF) variant in the sucrase-isomaltase (SI) encoding gene, causing CSID. The condition is characterized by gastrointestinal symptoms such as stomachache, diarrhea, and weight loss when consuming sucrose, the most common dietary sugar. However, the awareness of the condition in the population and the healthcare system seems to be limited, potentially leading to a higher healthcare burden. Hence, we aimed to investigate whether HO-carriers visit the healthcare system more with gastrointestinal symptoms compared to the control groups by using registry data.

Methods: We performed a case–control study identifying cases and controls using genotype information from the 1999– 2001 and 2005– 2010 Greenlandic health population cohorts. The cases were defined as HO LoF SI-carriers and controls were defined as non-carriers and were matched (1:1) on sex, age, place of residence, and European genetic admixture. We used electronic medical records to assess the number of electronic medical record contacts (EMRc) related to gastrointestinal symptoms and the number of gastrointestinal-related diagnostic procedures.

Results: A total of 80 HO-carriers and 80 non-carriers were included. The HO-carriers had 19% more EMRc related to gastrointestinal symptoms (IRR, 1.19, 95% CI [1.02;1.40], p=0.02) and had a 41% higher incidence of gastrointestinal related diagnostic procedures compared to controls (IRR, 1.41, 95% CI [1.05– 1.92], p=0.02). Only one HO-carrier was aware of the condition according to the electronic medical records.

Conclusion: HO-carriers of the LoF SI-variant had both significantly more gastrointestinal-related EMRc and significantly more diagnostic procedures conducted due to gastrointestinal symptoms. Only one HO-carrier was aware of the condition. Given the high prevalence of HO-carriers in the Greenlandic population, we anticipate that diagnosing more patients with CSID and providing dietary advice could potentially reduce symptom burden and healthcare visits among HO-carriers.

Keywords: Inuit, genetic metabolism, sucrase-isomaltase, Greenland, congenital sucrase-isomaltase deficiency, loss-of-function variant

Download Article

查看本刊最新文章
Advances and Applications in Bioinformatics and Chemistry

Advances and Applications in Bioinformatics and Chemistry
《生物信息学与化学的进展及应用》

期刊指标

2023影响因子:
6.5 (Q1)

ISSN:
1178-6949
年度下载/阅读量:
29,212
稿件接受率:
20%
提交新稿件 查看我的稿件状态

关于期刊

Advances and Applications in Bioinformatics and Chemistry(《生物信息学与化学的进展及应用》)是一本国际同行评审开放获取期刊,专注于计算生物学、化学信息学及药物设计领域的前沿研究,涵盖计算生物建模、基因组学分析、蛋白质结构预测、系统生物学及计算机ADME/Tox预测等方向,旨在顺利获得多学科整合有助于科学生命与化学研究的计算技术创新及转化应用。

本刊主要关注:

  • 计算生物建模(如分子动力学模拟优化酶催化机制)
  • 生物信息学与计算基因组学(如肿瘤基因组变异的功能注释)
  • 蛋白质结构预测与结构基因组学(如AlphaFold2改进膜蛋白建模)
  • 系统生物学(如代谢网络模型构建指导合成生物学设计)
  • 化学信息学与药物设计(如AI驱动的先导化合物虚拟筛选)
  • 计算机ADME/Tox预测(如机器学习预测药物肝毒性)

本刊是Committee on Publication Ethics (COPE) 的成员之一,遵循COPE的原则。期刊还被收录于Scopus 、PubMed 、DOAJ、OAIster等线上索引中。

已发表论文

Authors: Herlina T , Akili AWR , Nishinarizki V, Hardianto A , Latip J

Received: 22 January 2024

Accepted for publication: 3 May 2024

Published: 14 May 2024 Volume 2024:17 Pages 61—70

DOI: http://doi.org/10.2147/AABC.S454961

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Dr Maria Miteva

Purpose: This study aimed to screen potential drug candidates from the flavonoids of the genus Erythrina for the Corona Virus Disease 2019 (COVID-19) treatment.

Patients and Methods: A comprehensive screening was conducted on the structures of 473 flavonoids derived from the genus Erythrina, focusing on their potential toxicity and pharmacokinetic profiles. Subsequently, flavonoids that were non-toxic and possessed favorable pharmacokinetic properties underwent further analysis to explore their interactions with the angiotensin-converting enzyme 2 (ACE2) receptor, employing molecular docking and molecular dynamics simulations.

Results: Among 473 flavonoids, 104 were predicted to be safe from being mutagenic, hepatotoxic, and inhibitors of the human ether-a-go-go-related gene (hERG). Among these 104 flavonoids, 18 compounds were predicted not to be substrates of P-glycoprotein (P-gp). Among these 18 flavonoids, gangetinin ( 471) and erybraedin D ( 310) exhibit low binding affinities and root mean square deviation (RMSD) values, indicating stable binding to the ACE2 receptor. The physicochemical attributes of compounds 310 and 471 suggest that they possess drug-like properties.

Conclusion: Gangetinin ( 471) and erybraedin D ( 310) may serve as promising candidates for COVID-19 treatment due to their potential to inhibit the ACE2-RBD interaction. This warrants further investigation into their inhibitory effects on ACE2-RBD binding through in vitro experiments.

Keywords: structure-based virtual screening, Erythrina, flavonoids, angiotensin-converting enzyme 2, corona virus disease 2019

Graphical Abstract:

Download Article

Authors: Aulifa DL, Al Shofwan AA, Megantara S , Fakih TM , Budiman A

Received: 22 September 2023

Accepted for publication: 16 January 2024

Published: 23 January 2024 Volume 2024:17 Pages 1—19

DOI: http://doi.org/10.2147/AABC.S441628

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Dr Maria Miteva

Introduction: Amorphous drug dispersion is frequently used to enhance the solubility and dissolution of poorly water-soluble drugs, thereby improving their oral bioavailability. The dispersion of these drugs into polymer matrix can inhibit their recrystallization. The inter-molecular interactions between drug and polymer plays a role in the improvement of the dissolution rate, solubility, and physical stability of drug.

Aim: This study aims to investigate the formation and interactions of ritonavir (RTV)/poloxamer (PLX) amorphous formulation using a computational approach via molecular dynamics (MD) simulations, which mimicked solvent evaporation and melt-quenching method.

Methods: TheRoot Mean Square Deviation (RMSD) value, Root Mean Square Fluctuation (RMSF), Radial Distribution Function (RDF), Radius of Gyration (Rg), Solvent Accessible Surface Area (SASA), and hydrogen bond interactions were analyzed to determine interaction mechanisms between RTV and PLX in amorphous solid dispersion.

Results: The pi-alkyl bonds between RTV and PLX were formed after simulations of solvent evaporation, while the hydrogen bond interactions of RTV-PLX was observed during melt method simulations. These results indicate the successful formulation of amorphous solid dispersion (ASD) from RTV and PLX. The RMSD values obtained from the solvent evaporation, melt-cooling-A, melt-cooling-B, and melt-cooling-C methods were 3.33 Å, 1.97 Å, 1.30 Å, and 1.29 Å, respectively, while the average RMSF values were 2.65 Å, 1.04 Å, 1.05 Å, and 1.07 Å, respectively. This indicates that the suppression of translational motion of RTV from the melt method can be stronger than solvent evaporation caused by the intermolecular interactions of RTV-PLX.

Conclusion: MD simulations helped in understanding the formation and interaction mechanisms of ASD formulations that were difficult to detect by experimental approaches.

Keywords: amorphous solid dispersion, molecular interaction, molecular dynamics simulations, ritonavir, poloxamer

Download Article

查看本刊最新文章
Stem Cells and Cloning: Advances and Applications

Stem Cells and Cloning: Advances and Applications
《干细胞与克隆:进展与应用》

期刊指标

2023影响因子:
1.7 (Q4)
CiteScore:
6.5 (Q1)

ISSN:
1178-6957
年度下载/阅读量:
19,184
投稿至收到专家评审结果平均时间:
55天
稿件接受率:
62%
提交新稿件 查看我的稿件状态

关于期刊

Stem Cells and Cloning: Advances and Applications(《干细胞与克隆:进展与应用》专注于干细胞研究与克隆技术的基础科学、治疗应用及伦理探讨,涵盖胚胎干细胞、成体干细胞、治疗性克隆及再生医学创新,旨在顺利获得多学科交叉有助于干细胞技术从实验室向临床的转化,并促进伦理框架的构建。

本刊主要关注:

  • 干细胞生物学与技术创新:
    • 胚胎干细胞与成体干细胞的定向分化机制(表观遗传调控、信号通路解析)
    • 干细胞培养与转化技术优化(3D生物打印、类器官模型构建)
  • 治疗性克隆与再生医学应用:
    • 治疗性克隆技术在器官修复中的应用(自体细胞系构建、免疫排斥调控)
    • 脐带血与骨髓干细胞的临床前研究(血液病治疗、组织再生潜力验证)
  • 伦理与政策研究:
    • 干细胞研究的伦理争议与法律规范(胚胎使用边界、克隆技术监管政策)
    • 国际干细胞技术转化的社会接受度与政策适配性分析
  • 跨物种研究与技术验证
    • 动物模型在干细胞治疗中的验证(如帕金森病细胞替代疗法)
    • 人类临床试验设计与长期安全性追踪(如干细胞移植致瘤性评估)

中国科研实验室分区
根据2025年发布的中国科研实验室期刊分区表(升级版)显示:
  •  大类及分区:生物学4区
  •  小类及分区:细胞生物学4区

本刊是Committee on Publication Ethics (COPE) 的成员之一,遵循COPE的原则。期刊还被收录于ESCI、PubMed、Scopus、DOAJ、Embase、OAIster等线上索引中。

已发表论文

Authors: Saadeldin IM , Ehab S, Alshammari MEF, Abdelazim AM, Assiri AM

Received: 7 January 2025

Accepted for publication: 13 February 2025

Published: 18 February 2025 Volume 2025:18 Pages 15—34

DOI: http://doi.org/10.2147/SCCAA.S513982

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 2

Editor who approved publication: Dr Bernard Binetruy

Abstract: The mammalian oocyte is pivotal in reproductive biology, acting as a central hub for cellular reprogramming and stemness. It uniquely contributes half of the zygotic nuclear genome and the entirety of the mitochondrial genome, ensuring individual development and health. Oocyte-mediated reprogramming, exemplified by nuclear transfer, resets somatic cell identity to achieve pluripotency and has transformative potential in regenerative medicine. This process is critical for understanding cellular differentiation, improving assisted reproductive technologies, and advancing cloning and stem cell research. During fertilization, the maternal-zygotic transition shifts developmental control from maternal factors to zygotic genome activation, establishing totipotency. Oocytes also harbor reprogramming factors that guide nuclear remodeling, epigenetic modifications, and metabolic reprogramming, enabling early embryogenesis. Structures like mitochondria, lipid droplets, and cytoplasmic lattices contribute to energy production, molecular regulation, and cellular organization. Recent insights into oocyte components, such as ooplasmic nanovesicles and endolysosomal vesicular assemblies (ELVAS), highlight their roles in maintaining cellular homeostasis, protein synthesis, and reprogramming efficiency. By unraveling the reprogramming mechanisms inherent in oocytes, we advance our understanding of cloning, cell differentiation, and stem cell therapy, highlighting their valuable significance in developmental biology and regenerative medicine.

Keywords: reprogramming, oocytes, genome activation, epigenetics

Download Article

Authors: Fitriani N, Wilar G , Narsa AC , Elamin KM , Wathoni N

Received: 7 September 2024

Accepted for publication: 7 December 2024

Published: 10 January 2025 Volume 2025:18 Pages 1—13

DOI: http://doi.org/10.2147/SCCAA.S493125

Checked for plagiarism: Yes

Review by: Single anonymous peer review

Peer reviewer comments: 3

Editor who approved publication: Dr Bernard Binetruy

Objective: Chronic wounds are a common clinical problem that necessitate the exploration of novel regenerative therapies. We report a method to investigate the in vitro wound healing capacity of an innovative biomaterial, which is based on amniotic membrane-derived stem cells (AMSCs) embedded in an alginate hydrogel matrix. The aim of this study was to prepare an sodium alginate-based hydrogel, cross-linked calcium chloride (CaCl2) with the active ingredient AMSC (AMSC/Alg-H) and to evaluate its in vitro effectiveness for wound closure.

Methods: This hydrogel preparation involved combining sterile solutions of AMSC, sodium alginate, and CaCl2, followed by rinsing with serum-free media. The cells were cultured in different 6-well plates, namely sodium alginate, calcium chloride, AMSC, Alg-H, and AMSC/Alg-H, in complete medium with 10% FBS. The hydrogel was successfully formulated, as confirmed by characterization techniques including Scanning Electron Microscopy (SEM), Fourier Transform Infrared (FTIR) spectroscopy, Differential Scanning Calorimetry (DSC), Cytotoxicity Studies, TGF-β 1 Level Measurement by ELISA, and Cell Scratch Wound Assay.

Results: Cryo-EM characterization of the Alg-H preparation successfully demonstrated the encapsulation of MSCs. FTIR and DSC analyses indicate that crosslinking transpires in Alg-H encapsulating AMSC. The AMSC/Alg-H preparation showed no significant difference in toxicity compared to HaCaT cells (p < 0.05), indicating it was not toxic to HaCaT cells. Furthermore, in the scratch wound assay test at 24 hours, the AMSC/Alg-H preparation achieved 100% wound closure, outperforming both AMSC and Alg-H alone. In vitro assessment revealed that AMSC/Alg-H significantly enhanced key wound healing processes, including cell proliferation and migration, compared to Alg-H.

Conclusion: Our study demonstrated the promising potential of AMSC/Alg-H as an enhanced regenerative therapy for in vitro wound healing. AMSC/Alg-H was able to maintain the viability of AMSCs and facilitate the formation of tissue-like structures.

Keywords: AMSC, alginate, hydrogel, wound healing

Graphical Abstract:

Download Article

查看本刊最新文章

文稿出版费

开放获取出版模式:提交给 Dove Medical Press 的所有文稿,都将被认为是按照开放获取出版模式提交的。根据这种出版模式,文稿将由编辑安排进行同行审评。如果文稿获准出版,作者将收到一张付款发票,以便支付文稿出版处理费(参见下列付款详情)。Dove Medical Press 将用此收入来支付编辑费和制作费,并创建一个基金,用来资助来自开展中国家的作者,让他们能取得出版处理费的减免。出版的文稿将以电子文件的形式在线发表,读者可从我们的网站上免费获取。
作者也可以将用 PDF 格式发表的文稿发布在自己或单位的网站上。
一旦文稿获准出版,您就需要支付文稿出版费。费用金额可在期刊主页查询。由于外汇汇率的波动,费用可能出现间或性变化,恕不另行通知。
彩色插图: 开放获取式文稿皆为电子文件。由于没有任何 Dove Medical Press 期刊付诸印刷,因此在文稿中加入彩色插图不会产生任何额外费用。
具体文稿出版费用及更多信息,请查看 Author guidelines

作者指南

文稿基本结构

文章类型定义

请点击此处分析更多详情

标题页

- 作者的名/姓(请见下文有关原创作者部分)
- 作者所属单位: 科室,单位(组织)、城市、省(州)、国家
- 所有作者的 ORCID 编号 (如果可以给予)

文章摘要 

有两种类型的摘要-结构化的和非结构化的。原始的研究论文需要一个结构化的摘要。这两种类型的摘要都不能超过 300 字。

简明总结 (仅供选择) 

简明总结不仅有助于让文章得到更广泛的受众,而且还可以使相关学科的专业人员对该研究进行分析。更重要的,简明总结有利于增进公众对科学和医学研究的参与。顺利获得帮助公众分析生物医学研究,研究人员可以让公众认识其研究的价值,从而吸引更多的公众支持和参与。

作为一名作者,以一种吸引人的方式向更广泛的读者推广你的作品会帮助您: 

- 吸引更多的读者
- 可能会增加文章被引用的次数
- 建立良好的声誉
- 与病人、护理人员、政治家、决策者和其他决定者保持联系
- 吸引更多融资机会
- 拓展你的职业网络

简明的语言总结没有最少的字数限制,但应该不超过250个字。用简单易懂的英语撰写,并置于摘要之后,简介之前。简明总结应该与论文摘要不同,并且应该以一种通俗易懂、有趣的方式来写,而不是过于复杂或夸大。

- 简明总结不应该是您的论文的简易版本。不要低估您的读者或过分保护读者。
- 简明总结中应包括对以下问题的解答:为什么要完成这项研究?研究人员做了哪些工作及有何发现?这些研究结果意味着什么?
- 用有趣的方式传达事实,并把它们放在适当的背景下。
- 使用短而清晰的句子,分成几个段落,便于阅读。你也许可以使用要点符号。
- 使用主动语态而不是被动语态(例如: “史密斯博士的团队报告了几项改进” ,而不是 “几项改进由史密斯博士的团队报告”) 。
- 避免使用专业术语、复杂的语法结构或缩写。尽量使用常用英语单词,而不是复杂的单词。如果你需要使用专业术语或缩写,请在第一次使用时解释清楚。
- 用肯定的方式而不是否定的方式来构造句子。
- 使用以人为本的语言,而不是关注病情/疾病或残疾。
- 让一个对这个课题一无所知的人来阅读您的简明总结并给予反馈。他们应该会觉得很有趣,他们应该能够理解你的研究是什么,结论是什么,研究可能会产生什么影响。

关于如何使用简明英语撰写生物医学和健康研究的更多信息,请参阅National Institute for Health Research的 INVOLVE Plain English Summaries 的相关信息。

伦理批准和知情同意

所有关于人类(个人、样本或数据)或动物的研究,都必须包括伦理批准声明,如果涉及人体研究,则必须取得研究对象的知情同意。稿件中必须包含一段声明,以确认批准和同意该项研究的所属单位或组织的伦理委员会的全名。相关的伦理文件的参考号/伦理批准编号也应包括在声明里面。请参阅我们的编辑政策以取得更多信息。

同意出版声明

作者的同意出版声明必须确认稿件中的所有图像、视频、录音等详细资料都可以发表,并且声明同意者已经阅读了即将发表文章的所有内容。如果需要,作者必须准备向期刊编辑部给予签署的同意出版声明书的副本。请参阅我们的编辑政策以取得更多信息。

数据可用性(如果适用)

请在稿件中包括一个声明, 以说明稿件中所使用的支持研究结果的数据,可以在哪里找到和共享。 如果可以的话,也请给予公开存档的数据资料的链接。数据可用性声明也应该解释研究中那些额外的未发表的数据,(如果有的话)是可用的,能够给予给哪些人使用,以及如何取得这些数据。如果作者不希望分享他们的数据或不能分享,他们应该声明数据将不会被分享以及原因。请参阅我们的编辑政策,以取得更多信息。

资金

请申报所有资金来源,包括经费支持。请说明经费资助者从研究设计到论文提交发表的每个阶段所担当的具体角色(如果有的话)。如果经费资助者并没有参与论文的各个研究阶段,也请说明。 请确保此信息准确且符合经费资助者的要求。

利益冲突

您与他人或组织的关系,可能会影响您在研究中解释数据或展示信息的方式。这就是所谓的利益冲突,因而所有递交给Ebpay生命医学出版社所属期刊的论文作者,都被要求完成一份利益冲突声明。这包括所有财务或非财务性利益冲突,包括与研究赞助者的雇佣关系、股票持有或期权、专利、版税、个人费用、担任董事会职位,或与发表内容相关的任何政治、宗教或学术利益关系。所有利益冲突将在文章末尾的声明中列出。

更多“利益冲突”相关信息,请查看

成为作者的资格

在文章中列出作者姓名是向那些对这项工作做出重大贡献的人表示感谢的重要机制。 它还确保了负责内容完整性的人员的透明度。 文章中列出的作者必须满足以下所有标准:

- 对报告的工作做出了重大贡献,无论是在构思、研究设计、执行、数据采集、分析和解释,还是在所有这些领域。
- 起草或撰写、或大幅修改或批判性地审查了该文章。
- 已就文章投稿期刊达成一致。
- 在提交前、修改期间、接受出版的最终版本以及校对阶段引入的任何重大更改对文章的所有版本进行了审查并达成一致。
- 同意承担责任并对文章内容负责。

请点击此处分析更多详情

致谢

所有不符合成为原创作者但是对稿件有贡献的合作者都应该在致谢(Acknowledgment)部分中列出。这些应该致谢的人员包括那些给予了技术支持、协助撰写,或是给予了一般支持的系主任。作者应该声明他们是否在研究设计、数据收集,或是手稿的准备方面得到了协助。如果确实得到上述支持,作者应该在得到支持者本人允许的情况下,在文章中公开声明每位协助者的名字以及他们具体协助的相关事项。资金和物质方面的支持也应该被告知。

那些对文稿做出了极大贡献但是不符合成为原创作者的小组人员,可以列在 “临床研究人员” 或是 “参与研究人员” 名下,他们所做的工作或是贡献也应该写明,比如 “担任科学指导”,“严谨的审核了研究方案”、“收集数据” 或者是 “给予并照看了研究病人”。因为读者可能会认为作者发表的数据和结论同样得到这些协助人员的支持,这些小组人员也须对他们将被在文稿里致谢做出书面许可。

为了在 PubMed 上可以搜索到合作小组的个人成员(指在 PubMed 上列出的期刊),请确保:

- 在作者列表下的标题页上添加小组名称,例如 “On behalf of…”
- 在稿件中另加 “合作人员” 标题并列出所有合作人员,这必须是文本而不是表格,格式为名字、中间名首字母(可选)、姓氏
- “合作人员” 标题加在 “作者贡献” 和 “致谢” 之间的位置
- 或者可以给予一个列表作为补充材料,并在论文中包含一个链接

请注意, “合作人员” 名单只会出现姓名列表,不会列出所属单位。

由于 PubMed 需要额外的时间来编写这些合作小组,所以当一篇文章最初被收录在 PubMed 上时,这些小组可能不会同时出现。

请注意:我们的作者资格及 “致谢部分中列出的作出贡献者” 内容,转载自 ICMJE 对递交到生物医学期刊稿件的统一要求。Ebpay生命医药出版社准备了这份重印版。ICMJE 并没有授权或是背书我们的重印。有关 ICMJE 对递交到生物医学期刊稿件的统一要求的官方正式版本,请点击链接  http://www.icmje.org/ 。用户在引用文档时应引用此官方版本。

基于人工智能 (AI) 的内容生成工具和技术

作者必须意识到使用基于 AI 的工具和技术来生成文章内容,例如大型语言模型 (LLM)、生成式 AI 和聊天机器人(例如 ChatGPT)不符合我们的作者身份标准。
所有作者对其提交内容的原创性、有效性和完整性负全部责任。 因此,LLM 和其他类似类型的工具不符合作者资格标准。

声明:以上资讯是由英文翻译成中文。如英文版与中文版有不一致之处,一概以英文版为准:
http://www.dovepress.com/author_guidelines.php

关于Ebpay生命医药出版社

Dove Medical Press Ltd 隶属于Taylor & Francis Group,Informa PLC的学术出版部门,创建于2003年,在英国曼彻斯特和伦敦设有办事处,在美国新泽西州普林斯顿设有代表处,我们的编辑部在新西兰奥克兰。

我们专注于出版广泛的科学、技术,尤其是医学领域的开放获取同行评审期刊,目标是将最高的编辑标准与“同类最佳”的新出版技术相结合。

Dove Medical Press 是出版伦理委员会 (COPE) 的成员,并认可国际医学期刊编辑委员会 (ICMJE)。作为一家负责任的开放获取出版商,Dove Medical Press创建了这个页面来解决学术上的透明度和最佳实践原则。

您可能感兴趣的相关期刊

Advances and Applications in Bioinformatics and Chemistry Stem Cells and Cloning: Advances and Applications Integrated Pharmacy Research and Practice
Pharmacogenomics and Personalized Medicine Journal of Experimental Pharmacology Veterinary Medicine: Research and Reports
Drug Design, Development and Therapy Drug, Healthcare and Patient Safety Open Access Journal of Clinical Trials